Bridgebio Pharma shares owned by Vanguard Group
Quarter-by-quarter ownership of Bridgebio Pharma (BBIO) shares owned by Vanguard Group
from 13F filings
Historical chart of Vanguard Group investment in Bridgebio Pharma
Tip: Access up to 7 years of quarterly data
All positions including Bridgebio Pharma held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Bridgebio Pharma by Vanguard Group
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $517M | 13M | 40.37 |
| 2023-09-30 | $297M | 11M | 26.37 |
| 2023-06-30 | $201M | 12M | 17.20 |
| 2023-03-31 | $200M | 12M | 16.58 |
| 2022-12-31 | $81M | 11M | 7.62 |
| 2022-06-30 | $90M | 9.9M | 9.08 |
| 2022-03-31 | $96M | 9.4M | 10.15 |
| 2021-09-30 | $442M | 9.4M | 46.87 |
| 2021-06-30 | $691M | 11M | 60.96 |
| 2021-03-31 | $575M | 9.3M | 61.60 |
| 2020-12-31 | $458M | 6.4M | 71.11 |
| 2020-09-30 | $236M | 6.3M | 37.52 |
| 2020-06-30 | $189M | 5.8M | 32.61 |
| 2020-03-31 | $69M | 2.4M | 29.00 |
| 2019-12-31 | $75M | 2.1M | 35.05 |
| 2019-09-30 | $34M | 1.6M | 21.48 |